Registry for End Stage Renal Failure (REIN)

September 8, 2016 updated by: Centre Hospitalier de Cayenne

Réseau, Epidémiologie, Information, Néphrologie (Network Epidemiology Information Nephrology)

The rein registry collects case record data from patients with end stage renal disease followed in French Guiana. This allows to generate incidence and rates for terminal renal disease, mortality rates for each territory. The regional data are pooled in order to get national statistics for end stage renal disease and transplantation activity in order to adapt prevention to the main causes of renal failure and treatment and care infrastructure.

Study Overview

Status

Unknown

Conditions

End Stage Renal Failure

Intervention / Treatment

Other: Registry (No intervention)

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- French Guiana
  - Cayenne, French Guiana, France, 97306
    - Recruiting
    - General Hospital of Cayenne
    - Contact:
      
      Mathieu Nacher, MD, PhD
      
      Phone Number: 5024 0594395024
      
      Email: mathieu.nacher@ch-cayenne.fr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Child
Adult
Older Adult

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with End Stage Renal Failure followed in one of the dialisys sites in frnech Guiana

Description

Inclusion Criteria:

End Stage Renal Failure

Exclusion Criteria:

Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Death Time Frame: 10 years	10 years
Transplant Time Frame: 10 years	10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier de Cayenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

January 1, 2011

Study Completion (Anticipated)

January 1, 2021

Study Registration Dates

First Submitted

September 6, 2016

First Submitted That Met QC Criteria

September 8, 2016

First Posted (Estimate)

September 9, 2016

Study Record Updates

Last Update Posted (Estimate)